These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 3148810)
1. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810 [TBL] [Abstract][Full Text] [Related]
2. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y Microb Pathog; 1987 Jul; 3(1):21-30. PubMed ID: 3143036 [TBL] [Abstract][Full Text] [Related]
3. Characterization of purified Shiga toxin from Shigella dysenteriae 1. Yutsudo T; Honda T; Miwatani T; Takeda Y Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915 [TBL] [Abstract][Full Text] [Related]
4. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533 [TBL] [Abstract][Full Text] [Related]
5. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin. Kongmuang U Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395 [TBL] [Abstract][Full Text] [Related]
6. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Brown JE; Griffin DE; Rothman SW; Doctor BP Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of an Escherichia coli Shiga-like toxin II variant. MacLeod DL; Gyles CL Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539 [TBL] [Abstract][Full Text] [Related]
8. Purification of a lethal toxin produced by Shigella dysenteriae. Okamoto K; Takeda Y; Miwatani T Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787 [TBL] [Abstract][Full Text] [Related]
9. Purification and physicochemical properties of a unique Vero cell cytotoxin from Escherichia coli O157:H7. Padhye VV; Kittell FB; Doyle MP Biochem Biophys Res Commun; 1986 Sep; 139(2):424-30. PubMed ID: 3533062 [TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits. Yutsudo T; Honda T; Miwatani T; Takeda Y Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622 [TBL] [Abstract][Full Text] [Related]
11. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea. Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. O'Brien AD; LaVeck GD Infect Immun; 1983 May; 40(2):675-83. PubMed ID: 6341244 [TBL] [Abstract][Full Text] [Related]
13. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Strockbine NA; Marques LR; Newland JW; Smith HW; Holmes RK; O'Brien AD Infect Immun; 1986 Jul; 53(1):135-40. PubMed ID: 3522426 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a phage-encoded cytotoxin from an Escherichia coli O111 strain associated with hemolytic-uremic syndrome. Karch H; Bitzan M Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):41-51. PubMed ID: 2464885 [TBL] [Abstract][Full Text] [Related]
15. Purification of an Escherichia coli serogroup O157:H7 verotoxin and its detection in North American hemorrhagic colitis isolates. Dickie N; Speirs JI; Akhtar M; Johnson WM; Szabo RA J Clin Microbiol; 1989 Sep; 27(9):1973-8. PubMed ID: 2674193 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471 [TBL] [Abstract][Full Text] [Related]
18. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179 [TBL] [Abstract][Full Text] [Related]
19. Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7. Ito H; Yutsudo T; Hirayama T; Takeda Y Microb Pathog; 1988 Sep; 5(3):189-95. PubMed ID: 3063913 [TBL] [Abstract][Full Text] [Related]
20. Purification of recombinant shiga-like toxin type I B subunit. Austin PR; Hovde CJ Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]